Options Strengthens North America Presence with New York Office Expansion In the Heart of Wall Street July 28, 2026 Options Technology (Options), the leading provider of IT infrastructure to global financial institution managed services, today announced the expansion of its New York office. This expansion comes after increased client growth and surging demand across North America for the firm’s trading infrastructure and market data solutions. The 34,000 square foot office, located in the heart [...]
Airspan Delivers Revenue Growth and Profitability in First Half 2026 July 27, 2026 Revenue growth and a strong financial foundation
Result of AngloGold Ashanti plc’s General Meeting July 24, 2026 AngloGold Ashanti plc (the “Company”) (NYSE: AU; JSE: ANG) today announces the result of the general meeting of its shareholders held at 9:00am (Mountain Daylight Time) on Thursday, 23 July 2026 (the “General Meeting”). The full text of the resolution proposed at the General Meeting is set out in the notice of General Meeting (the [...]
Almirall H1 2026 Results July 24, 2026 Almirall delivers solid H1 2026 results growing Net Sales by 7.5% and EBITDA by 23.7%, driven by its strong European Dermatology business – reiterating guidance aligned with long-term growth trajectory Net Sales increased by 7.5% YoY to €602.7 MM, while EBITDA grew by 23.7% to €150.7 MM, reflecting strong commercial and operational execution. The European Dermatology business continues to drive growth, increasing 18.1% YoY to €341.9 MM, supported by strong performance of its key growth drivers and favourable underlying market growth. Continued solid performance of the biologics portfolio, with Ilumetri® delivering 10.5% increase to €125.2 MM and Ebglyss® growing 88.2% to €84.5 MM in Net Sales, supported by sustained growth in recent launch markets. The broader dermatology portfolio delivers positive performance, including Wynzora® (19.3%, total of €20.4 MM) and Klisyri® (13.9%, total of €15.6 MM). Almirall advances its innovation strategy through progress across its R&D pipeline, including four ongoing PoC/Phase II studies and two additional PoC studies planned to be initiated by end of 2026, targeting five dermatological diseases. The first readouts are expected towards the end of 2026. Almirall signs a strategic research collaboration and licensing agreement with Certest Biotec to discover and develop novel treatments for rare dermatologic diseases and recurrent cutaneous conditions. Reiterated guidance for the full year 2026: 9-12% growth and € 270MM to € 290MM EBITDA.
ATOZ Services Announces Strategic Growth Investment from Bregal Sagemount July 23, 2026 Investment will support geographic expansion, AI investment and continued growth across ATOZ Services’ fund services platform
Invested as One: Northern Trust Grants Employees Company Stock July 21, 2026 Northern Trust Ties its One Northern Trust Strategy to Employee Ownership
RealPage Acquires Cherre, Creating a Trusted AI-Powered Intelligence Platform Across the Full Real Estate Capital Stack July 14, 2026 Combination connects property-level operations with institutional portfolio intelligence, giving owners and operators a governed, trusted foundation for better decisions and stronger performance.
Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION July 14, 2026 Non-arteritic anterior ischemic optic neuropathy (NAION) is a loss of blood flow to the optic nerve which causes spontaneous and rapid vision loss, for which there are currently no FDA-approved treatments. Given the substantial unmet need for effective treatments in NAION, in October 2025, Dompé was awarded a Commissioner’s National Priority Review Voucher (CNPV) by the US FDA to accelerate a potential Biologics License Application for intranasal nerve growth factor (NGF) in NAION.
DEWA International Launched as a Wholly Owned Independent Subsidiary of DEWA to Develop Global Energy and Water Projects July 9, 2026 HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, announced the establishment of ‘DEWA International’, a wholly owned independent subsidiary of Dubai Electricity and Water Authority (DEWA). The company aims to develop conventional and clean energy projects worldwide and export Dubai’s successful energy and water infrastructure model to global [...]
LR Invests Over €2 Million in Quality and Growth July 9, 2026 Global demand for innovative health products continues to grow, and with it the requirements for quality, supply reliability and production capacity. LR Health & Beauty is therefore strengthening its Ahlen headquarters with an investment of more than €2 million, laying the foundation for further growth. This press release features multimedia. View the full release here: [...]